These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14086115)

  • 21. [IDENTIFICATION OF EATON'S AGENT (MYCOPLASMA PNEUMONIAE) AS THE PATHOGEN IN PRIMARY ATYPICAL PNEUMONIA IN CZECHOSLOVAKIA].
    SOBESLAVSKY O; DANESOVA J
    Cesk Epidemiol Mikrobiol Imunol; 1963 Sep; 12():257-61. PubMed ID: 14087436
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence of antibodies to Mycoplasma pneumoniae at a Veterans Administration Medical Center.
    Reiber DT; Flournoy DJ
    J Okla State Med Assoc; 1989 May; 82(5):213-5. PubMed ID: 2501465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STUDIES ON EATON AGENT IN TISSUE CULTURE.
    CLYDE WA
    Am Rev Respir Dis; 1963 Sep; 88():SUPPL 212-7. PubMed ID: 14064934
    [No Abstract]   [Full Text] [Related]  

  • 24. Determination of antibody to Mycoplasma pneumoniae by enzyme-linked immunosorbent assay II. Serum antibody in patients with Mycoplasma pneumoniae infections.
    Miyaji T
    Sci Rep Res Inst Tohoku Univ Med; 1984 Oct; 31(1-4):13-26. PubMed ID: 6442011
    [No Abstract]   [Full Text] [Related]  

  • 25. [The use of the complement fixation inhibition test for the detection of incomplete antibodies against Mycoplasma pneumoniae].
    Kruglikov VT; Zharkova LD
    Lab Delo; 1986; (12):752-3. PubMed ID: 2434723
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serologic diagnosis of chlamydial and Mycoplasma pneumoniae infections].
    de Barbeyrac B; Obeniche F; Ratsima E; Labrouche S; Moraté C; Renaudin H; Pereyre S; Bébéar CM; Bébéar C
    Ann Biol Clin (Paris); 2006; 64(5):409-19. PubMed ID: 17040871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial.
    Alexander TS; Gray LD; Kraft JA; Leland DS; Nikaido MT; Willis DH
    J Clin Microbiol; 1996 May; 34(5):1180-3. PubMed ID: 8727899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Growth inhibiting antibody of serum to Mycoplasma pneumoniae. 1. Evaluation of measurement of growth inhibiting antibody by fermentation inhibition test].
    Hasegawa S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1972 May; 10(5):251-62. PubMed ID: 4677094
    [No Abstract]   [Full Text] [Related]  

  • 29. ROLE OF MYCOPLASMA (PPLO) IN HUMAN RESPIRATORY DISEASE.
    CHANOCK RM; MUFSON MA; SOMERSON NL; COUCH RB
    Am Rev Respir Dis; 1963 Sep; 88():SUPPL 218-39. PubMed ID: 14064935
    [No Abstract]   [Full Text] [Related]  

  • 30. Serologic response to Mycoplasma pneumoniae infection. I. Evaluation of immunofluorescence, complement fixation, indirect hemagglutination, and tetrazolium reduction inhibition tests for the diagnosis of infection.
    Taylor-Robinson D; Sobĕslavsyý O; Jensen KE; Senterfit LB; Chanock RM
    Am J Epidemiol; 1966 Mar; 83(2):287-98. PubMed ID: 5326390
    [No Abstract]   [Full Text] [Related]  

  • 31. Mycoplasma pneumoniae protein involved in the antibody response in human infection.
    Räisänen S; Suni JI; Vaheri A
    J Clin Pathol; 1984 Oct; 37(10):1129-33. PubMed ID: 6436337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serologic response to Myocplasma pneumoniae infection. II. Significance of antibody measured by different techniques.
    Taylor-Robinson D; Shirai A; Sobĕslavský O; Chanock RM
    Am J Epidemiol; 1966 Sep; 84(2):301-13. PubMed ID: 5331213
    [No Abstract]   [Full Text] [Related]  

  • 33. The limitations of IgM assays in the serological diagnosis of Mycoplasma pneumoniae infections.
    Sillis M
    J Med Microbiol; 1990 Dec; 33(4):253-8. PubMed ID: 2124271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of five commercial tests: complement fixation, microparticle agglutination, indirect immunofluorescence, enzyme-linked immunosorbent assay and latex agglutination, in comparison to immunoblotting for Mycoplasma pneumoniae serology.
    Aubert G; Pozzetto B; Gaudin OG; Hafid J; Mbida AD; Ros A
    Ann Biol Clin (Paris); 1992; 50(8):593-7. PubMed ID: 1294015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnostic value of determination of IgM antibodies against Mycoplasma pneumoniae by the indirect immunofluorescent antibody test.
    Skaug K; Eng J; Orstavik I; Haug KW
    Acta Pathol Microbiol Scand B; 1976 Aug; 84(4):170-6. PubMed ID: 785942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Growth inhibiting antibody of serum to Mycoplasma pneumoniae. 3. Significance of serum growth inhibiting antibody in M. pneumoniae infections].
    Hasegawa S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1972 Jun; 10(6):330-45. PubMed ID: 4677016
    [No Abstract]   [Full Text] [Related]  

  • 37. MYCOPLASMA PNEUMONIAE INFECTIONS. CLINICAL AND EPIDEMIOLOGIC STUDIES.
    GRAYSTON JT; ALEXANDER ER; KENNY GE; CLARKE ER; FREMONT JC; MACCOLL WA
    JAMA; 1965 Feb; 191():369-74. PubMed ID: 14232437
    [No Abstract]   [Full Text] [Related]  

  • 38. A micro-capture ELISA for detecting Mycoplasma pneumoniae IgM: comparison with indirect immunofluorescence and indirect ELISA.
    Wreghitt TG; Sillis M
    J Hyg (Lond); 1985 Apr; 94(2):217-27. PubMed ID: 3921607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biological diagnosis of Mycoplasma pneumoniae respiratory infections].
    Bebear C
    Rev Mal Respir; 1986; 3(2):67-71. PubMed ID: 3088689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Chlamydia trachomatis and Mycoplasma pneumoniae in acute pharyngitis in children.
    Gerber MA; Randolph MF; Chanatry J; Mayo DR; Schachter J; Tilton RC
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):263-5. PubMed ID: 3105949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.